UPDATE: APBiotech Says it Leads China, Brazil Sequencing Markets | GenomeWeb

NEW YORK, Jan 19 - With the sale of over 60 MegaBace DNA analysis systems to research institutes in China and Brazil, Amersham Pharmacia Biotech said Friday that it is poised to dominate these markets.

These sales give AP Biotech “a market leading position” in the Latin American and Asia Pacific high-throughput sequencing markets, said Tracy Cheung, vice president of investo

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.